The Preimplantation Genetic Testing Market was valued at USD 791.50 million in 2023, projected to reach USD 1849.38 million by 2032 with a CAGR of 9.93%. The U.S. market alone was valued at USD 229.42 million in 2023, forecasted to expand to USD 528.43 million by 2032 with a CAGR of 9.76%. Demand for PGT is rising globally as fertility clinics expand, IVF cycles increase, and technologies improve accuracy.
Preimplantation genetic testing plays a crucial role in modern fertility care. As infertility rates rise and more individuals turn to assisted reproductive technologies, accurate genetic screening before embryo transfer becomes essential. These tests identify chromosomal abnormalities and single gene disorders, enhancing the chances of healthy pregnancies and reducing the risk of hereditary conditions.
Key players in the Preimplantation Genetic Testing market include Illumina, Thermo Fisher Scientific, PerkinElmer, and Natera. In 2023, the Preimplantation Genetic Diagnosis segment dominated the market, responsible for screening embryos for hereditary genetic disorders before implantation. Reagents and Consumables led the market in product segmentation, while PCR technology dominated with its accuracy, cost-effectiveness, and extensive usage.
North America held a 40.08% market share in 2023, dominating the Preimplantation Genetic Testing market due to its advanced healthcare infrastructure and extensive use of assisted reproductive technologies. The Asia Pacific region is the fastest-growing, with a 10.89% CAGR, driven by rising infertility rates and increased adoption of ART. Recent developments include Thermo Fisher Scientific launching new research-use assays for reproductive health and QIAGEN introducing a dPCR Custom Assay Design Tool for CNV analysis. The Preimplantation Genetic Testing (PGT) market report offers insights into IVF cycle volumes, genetic disorder prevalence, regulatory impact, technology adoption, cost analysis, and fertility center expansion metrics for 2023-2032. Understand market trends, adoption rates, and regional impacts to make informed decisions in the evolving fertility treatment landscape. Access the full report for detailed analysis and outlook. Contact SNS Insider for customizable research and market insights to navigate changing market dynamics with confidence.
Read more at GlobeNewswire: Preimplantation Genetic Testing Market Size to Reach USD